mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.07 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.08 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.08 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.08 |